Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

BACKGROUND AND OBJECTIVE: Pulmonary tuberculosis (TB) is a risk factor for chronic obstructive pulmonary disease (COPD); however, few clinical studies have investigated treatment effectiveness in COPD patients with destroyed lung by TB. The Indacaterol effectiveness in COPD patients with Tuberculosi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Kim, Cheong-Ju, Yoon, Hyoung-Kyu, Park, Myung-Jae, Yoo, Kwang-Ha, Jung, Ki-Suck, Park, Jeong-Woong, Lim, Seong Yong, Shim, Jae Jeong, Lee, Yong Chul, Kim, Young-Sam, Oh, Yeon-Mok, Kim, Song, Yoo, Chul-Gyu
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459963/
https://ncbi.nlm.nih.gov/pubmed/28615931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S128750
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky